Cargando…

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeutic window for immunotherapies because of its asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez-Muñoz, Laia, Perna-Barrull, David, Caroz-Armayones, Josep M., Murillo, Marta, Rodriguez-Fernandez, Silvia, Valls, Aina, Vazquez, Federico, Perez, Jacobo, Corripio, Raquel, Castaño, Luis, Bel, Joan, Vives-Pi, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904370/ https://www.ncbi.nlm.nih.gov/pubmed/35280980 http://dx.doi.org/10.3389/fimmu.2022.825426

Ejemplares similares

NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes
por: Gomez-Muñoz, Laia, et al.
Publicado: (2021)

Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion
por: Gomez-Muñoz, Laia, et al.
Publicado: (2023)

Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
por: Perna-Barrull, David, et al.
Publicado: (2022)

Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2019)

Precarious housing and health inequalities in Spain since the crisis
por: Caroz Armayones, J M
Publicado: (2023)

Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
por: Perna-Barrull, David, et al.
Publicado: (2020)

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020)

Health-related quality of life (HRQOL) and its associated factors in children with Type 1 Diabetes Mellitus (T1DM)
por: Murillo, Marta, et al.
Publicado: (2017)

Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
por: Villalba, Adrian, et al.
Publicado: (2020)

Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
por: Perna-Barrull, David, et al.
Publicado: (2022)

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2018)

Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
por: Perna-Barrull, David, et al.
Publicado: (2019)

Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity
por: Gieras, Anna, et al.
Publicado: (2017)

Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study
por: Mayoral, Karina, et al.
Publicado: (2019)

Biomedical Holistic Ontology for People with Rare Diseases
por: Subirats, Laia, et al.
Publicado: (2020)

Partial remission, residual symptoms, and relapse in depression
por: Paykel, E.S.
Publicado: (2008)

Verbal memory functioning in recurrent depression during partial remission and remission-Brief report
por: Hammar, Åsa, et al.
Publicado: (2013)

Public knowledge of low vision and blindness, and readability of on-topic online information
por: Lupón, Marta, et al.
Publicado: (2021)

Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
por: Lee, Taewoo, et al.
Publicado: (2020)

Evaluación de la calidad de sitios web españoles con información sobre discapacidad visual
por: Lupón Bas, Marta, et al.
Publicado: (2019)

Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes
por: Teniente-Serra, Aina, et al.
Publicado: (2021)

Partial remission of advanced untreated Sézary syndrome after COVID-19
por: Snowden, Caroline, et al.
Publicado: (2022)

New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes
por: Mortensen, Henrik B., et al.
Publicado: (2009)

Partial remission with transarterial embolization in a case of metastatic adrenal cortical carcinoma.
por: Koh, M. S., et al.
Publicado: (1991)

Mining Facebook Data of People with Rare Diseases: A Content-Based and Temporal Analysis
por: Subirats, Laia, et al.
Publicado: (2018)

Maternal Microchimerism: Increased in the Insulin Positive Compartment of Type 1 Diabetes Pancreas but Not in Infiltrating Immune Cells or Replicating Islet Cells
por: Ye, Jody, et al.
Publicado: (2014)

NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development
por: Corral-Pujol, Marta, et al.
Publicado: (2023)

Effects of Bifidobacterium animalis Subsp. lactis (BPL1) Supplementation in Children and Adolescents with Prader–Willi Syndrome: A Randomized Crossover Trial
por: Amat-Bou, Montse, et al.
Publicado: (2020)

Phenotype of regulatory T cells in human type 1 diabetes at diagnosis and partial remission phase
por: da Silva Camilo, Daniela, et al.
Publicado: (2015)

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab
por: Stüven, Anna Kathrin, et al.
Publicado: (2019)

Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
por: Gülpen, Joost, et al.
Publicado: (2023)

Metabolic status in children with Cushing’s disease and its relationship with remission
por: Moszczyńska, Elżbieta, et al.
Publicado: (2023)

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review
por: Vives-Pi, Marta, et al.
Publicado: (2015)

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021)

Porokeratotic Eccrine Ostial and Dermal Duct Nevus Showing Partial Remission by Topical Photodynamic Therapy
por: Kim, Woo Joong, et al.
Publicado: (2011)

Data on correlations between T cell subset frequencies and length of partial remission in type 1 diabetes
por: Narsale, Aditi, et al.
Publicado: (2016)

Tumour Lysis Syndrome and Partial Remission Occurring After Administration of a Test Dose of Obinutuzumab
por: Mustafa, Mohamad, et al.
Publicado: (2017)

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study
por: Schulman, Jacqueline M., et al.
Publicado: (2017)

Influence of Age on Partial Clinical Remission among Children with Newly Diagnosed Type 1 Diabetes
por: Passanisi, Stefano, et al.
Publicado: (2020)

Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
por: Shi, Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_esbhcu8cm852kuh4si3nn5ppuv